奥马珠单抗对非自身免疫性荨麻疹有效。 - Suppr

Omalizumab is effective in nonautoimmune urticaria.

作者信息

Ferrer Marta, Gamboa Pedro, Sanz Maria L, Goikoetxea Maria Jose, Cabrera-Freitag Paula, Javaloyes Gracia, Berroa Felicia, Kaplan Allen P

出版信息

J Allergy Clin Immunol. 2011 May;127(5):1300-2. doi: 10.1016/j.jaci.2010.12.1085. Epub 2011 Feb 11.

DOI:10.1016/j.jaci.2010.12.1085

PMID:21315432

Abstract

摘要

相似文献

Omalizumab is effective in nonautoimmune urticaria.

J Allergy Clin Immunol. 2011 May;127(5):1300-2. doi: 10.1016/j.jaci.2010.12.1085. Epub 2011 Feb 11.

A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria.

J Allergy Clin Immunol. 2011 Sep;128(3):567-73.e1. doi: 10.1016/j.jaci.2011.06.010. Epub 2011 Jul 18.

Therapeutic alternatives for chronic urticaria: additional reports on omalizumab.

Ann Allergy Asthma Immunol. 2008 Dec;101(6):647. doi: 10.1016/S1081-1206(10)60232-3.

Omalizumab in chronic spontaneous urticaria: patient-tailored tapering or planned discontinuation?

Ann Allergy Asthma Immunol. 2015 Aug;115(2):147-8. doi: 10.1016/j.anai.2015.05.005. Epub 2015 Jun 2.

Monitoring omalizumab treatment efficacy in chronic urticaria by the basophil activation test.

Allergol Immunopathol (Madr). 2012 Nov-Dec;40(6):390-2. doi: 10.1016/j.aller.2011.09.009. Epub 2011 Dec 15.

Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysis.

J Dermatol Sci. 2014 Jan;73(1):57-62. doi: 10.1016/j.jdermsci.2013.08.011. Epub 2013 Sep 3.

Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase.

J Allergy Clin Immunol. 2011 Jul;128(1):202-209.e5. doi: 10.1016/j.jaci.2011.04.038. Epub 2011 Jun 2.

Effective treatment of therapy-resistant chronic spontaneous urticaria with omalizumab.

J Allergy Clin Immunol. 2010 Sep;126(3):665-6. doi: 10.1016/j.jaci.2010.05.047. Epub 2010 Jul 31.

Retreatment with omalizumab results in rapid remission in chronic spontaneous and inducible urticaria.

JAMA Dermatol. 2014 Mar;150(3):288-90. doi: 10.1001/jamadermatol.2013.8705.

Omalizumab in chronic urticaria.

Curr Opin Allergy Clin Immunol. 2012 Aug;12(4):406-11. doi: 10.1097/ACI.0b013e328355365a.

引用本文的文献

Emerging Therapies in Chronic Spontaneous Urticaria.

Allergy Asthma Immunol Res. 2019 Jul;11(4):470-481. doi: 10.4168/aair.2019.11.4.470.

Does omalizumab treatment affect serum dehydroepiandrosterone sulphate levels in chronic idiopathic urticaria?

Postepy Dermatol Alergol. 2019 Feb;36(1):92-97. doi: 10.5114/ada.2018.75328. Epub 2019 Feb 22.

Benefits and Harms of Omalizumab Treatment in Adolescent and Adult Patients With Chronic Idiopathic (Spontaneous) Urticaria: A Meta-analysis of "Real-world" Evidence.

JAMA Dermatol. 2019 Jan 1;155(1):29-38. doi: 10.1001/jamadermatol.2018.3447.

Chronic Spontaneous Urticaria: The Devil's Itch.

J Allergy Clin Immunol Pract. 2018 Jul-Aug;6(4):1097-1106. doi: 10.1016/j.jaip.2018.04.013.

Anti-IgE Treatment for Disorders Other Than Asthma.

Front Med (Lausanne). 2017 Sep 21;4:152. doi: 10.3389/fmed.2017.00152. eCollection 2017.

Omalizumab efficacy in cases of chronic spontaneous urticaria is not explained by the inhibition of sera activity in effector cells.

Sci Rep. 2017 Aug 21;7(1):8985. doi: 10.1038/s41598-017-09361-4.

Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria.

Allergy. 2017 Apr;72(4):519-533. doi: 10.1111/all.13083. Epub 2017 Jan 4.

Profile of omalizumab in the treatment of chronic spontaneous urticaria.

Drug Des Devel Ther. 2015 Aug 25;9:4909-15. doi: 10.2147/DDDT.S56004. eCollection 2015.

Omalizumab for difficult-to-treat dermatological conditions: clinical and immunological features from a retrospective real-life experience.

Clin Drug Investig. 2015 Mar;35(3):159-68. doi: 10.1007/s40261-015-0267-9.

Management of urticaria: not too complicated, not too simple.

Clin Exp Allergy. 2015 Apr;45(4):731-43. doi: 10.1111/cea.12465.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Omalizumab is effective in nonautoimmune urticaria.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献